Scott Perlman Received Approval from the FDA for the Clinical Use of 18F-Fluorocholine PET/CT in Patients with Parathyroid Adenomas
Dr. Scott Perlman Scott Perlman, MD, MS recently received approval by the Food and Drug Administration (FDA) to use 18F-Fluorocholine to improve detection and localization of parathyroid adenomas that had previously been difficult to localize. Dr. ...
April 11th, 2022